Free Trial

Daré Bioscience (DARE) SEC Filings & 10K Form

Daré Bioscience logo
$2.90 +0.01 (+0.35%)
Closing price 04:00 PM Eastern
Extended Trading
$2.88 -0.02 (-0.52%)
As of 04:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Daré Bioscience SEC Filings

DateFilerForm TypeView
04/24/2025
4:03 PM
Daré Bioscience (Filer)
Form ARS
04/11/2025
4:15 PM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
3:01 PM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
3:01 PM
Daré Bioscience (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/10/2025
7:01 AM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2025
4:34 PM
Daré Bioscience (Issuer)
Haring-Layton MarDee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
4:31 PM
Daré Bioscience (Issuer)
JOHNSON SABRINA MARTUCCI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:01 AM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
7:05 AM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
11:15 PM
Daré Bioscience (Filer)
Form EFFECT
11/26/2024
4:17 PM
Daré Bioscience (Filer)
Form 424B3
11/22/2024
4:00 PM
Daré Bioscience (Filer)
Form D
Notice of Exempt Offering of Securities 
11/15/2024
4:18 PM
Daré Bioscience (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/25/2024
7:01 AM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
11:31 AM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
4:00 PM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
7:05 AM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
3:15 PM
Daré Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
4:15 PM
Daré Bioscience (Issuer)
Matz Gregory W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:15 PM
Daré Bioscience (Issuer)
Kelley Susan L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:15 PM
Daré Bioscience (Issuer)
RASTETTER WILLIAM H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:15 PM
Daré Bioscience (Issuer)
Steele Robin Joan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:15 PM
Daré Bioscience (Issuer)
Grossman Jessica D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DARE) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners